$同源康医药-B(0_老虎社区_美港股上老虎

$同源康医药-B(02410)$ 公司董事长吴豫生曾表示TY-9591国内峰值年销售额不会差，针对脑转移及L858R突变市场潜力显著；公司管线共包括11款候选药物，当前收入主要是与丽珠医药的授权协议

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":625011576923344,"tweetId":"625011576923344","gmtCreate":1793605858284,"gmtModify":1793605860596,"author":{"id":4184380269673420,"idStr":"4184380269673420","authorId":4184380269673420,"authorIdStr":"4184380269673420","name":"骏马飞驰吧","avatar":"https://static.tigerbbs.com/d3702f332c2e6980d8637b92198e2a1c","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":14,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 公司董事长吴豫生曾表示TY-9591国内峰值年销售额不会差，针对脑转移及L858R突变市场潜力显著；公司管线共包括11款候选药物，当前收入主要是与丽珠医药的授权协议</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 公司董事长吴豫生曾表示TY-9591国内峰值年销售额不会差，针对脑转移及L858R突变市场潜力显著；公司管线共包括11款候选药物，当前收入主要是与丽珠医药的授权协议</p></body></html>","text":"$同源康医药-B(02410)$ 公司董事长吴豫生曾表示TY-9591国内峰值年销售额不会差，针对脑转移及L858R突变市场潜力显著；公司管线共包括11款候选药物，当前收入主要是与丽珠医药的授权协议","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/625011576923344","repostId":0,"isVote":1,"tweetType":1,"viewCount":122,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02410"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":168,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}